Xconomy National

Archives

by in
Entry Author Date Location
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M Luke Timmerman 08/19/11 Seattle
Pathway Medical Grinds It Out, Seeks Profit Formula, Three Years After FDA Approval Luke Timmerman 06/08/11 Seattle
Gilead Bets $600M on Cancer, Genentech Gets a Hearing, Jennerex Shows Early Survival Edge, & More Bay Area Life Sciences News Luke Timmerman 02/25/11 San Francisco
Pearl Hires New CEO Luke Timmerman 02/24/11 San Francisco
Ocular Therapeutix Grabs $14M in New Round for Eye Therapies Ryan McBride 02/03/11 Boston
Molecular Insight Pharma, Xconomy’s Neighbor, Faces Uncertain Future in Chapter 11 Ryan McBride 01/31/11 Boston
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010 Luke Timmerman 09/20/10 San Francisco
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior Ryan McBride 09/20/10 Boston
CombinatoRx Becomes Zalicus Erin Kutz 09/09/10 Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News Erin Kutz 06/04/10 Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News Erin Kutz 06/02/10 Boston
Covidien to Buy Ev3 for $2.6B Ryan McBride 06/01/10 Boston
ImThera Medical Generating Buzz Over Neurostimulation for Sleep Apnea Bruce V. Bigelow 03/05/10 San Diego
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News Erin Kutz 03/05/10 Boston
CombinatoRx Grabs $40M with FDA Approval Ryan McBride 03/02/10 Boston
Lantheus Medical Imaging Stakes Future on Innovation After Generic Hit to Key Product Ryan McBride 02/16/10 Boston
Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year Luke Timmerman 11/30/09 Seattle
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News Rebecca Zacks 10/02/09 Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News Ryan McBride 09/30/09 Boston
Covidien to Buy Aspect Medical for $210M Robert Buderi 09/28/09 Boston
I-Therapeutix Raises $15M in Round Led by Polaris Ryan McBride 06/19/09 Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News Rebecca Zacks 10/01/08 Boston
Covidien Cuts Costs in All Four Business Units, Corporate Luke Timmerman 09/29/08 Boston
The “Augmenix” Question: Can Amar Sawhney Do It Again with Latest Hydrogel Startup? Ryan McBride 09/04/08 Boston
Corporate Life Sciences VCs on the Rise in New England—the List Ryan McBride 09/03/08 Boston
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News Rebecca Zacks 08/20/08 Boston
Covidien Launches Venture Arm Ryan McBride 08/19/08 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.